South Texas Accelerated Research Therapeutics
In research, South Texas Accelerated Research Therapeutics stands highest in Medicine (#13,217 of 17,978 worldwide) and Health Sciences (#16,389 of 20,462 worldwide), over all time.
- World rank, 2022–2025
- #15,543 of 28,054 · #20,720 all time
- Rank in United States
- #2,195 of 4,192
- Research works
- 273 ▲ 21% vs 2013–17
- Citations
- 6.9k 25.4 per fractional work
- Top-10% rate
- 15.8% record average 16.5%
- Open access
- 29% world 28%
What is South Texas Accelerated Research Therapeutics known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #13,217 of 17,978 | 18.2% | 158 | |
| Health SciencesDomain | #16,389 of 20,462 | 18.2% | 160 |
Each strip is that field’s whole ranked pool, with the notch where South Texas Accelerated Research Therapeutics sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.3×. Every wedge is a field page.
- Immunology and Microbiology 6.3×
- Biochemistry, Genetics and Molecular Biology 3.8×
- Medicine 3.1×
- Pharmacology, Toxicology and Pharmaceutics 1.0×
- Physics and Astronomy 0.7×
- Economics, Econometrics and Finance 0.5×
- Health Professions 0.3×
- Neuroscience 0.3×
- Psychology 0.2×
- Social Sciences 0.2×
- Engineering 0.2×
- Agricultural and Biological Sciences 0.2×
- Nursing 0.2×
- Arts and Humanities 0.2×
- Business, Management and Accounting 0.2×
- Chemistry 0.1×
- Materials Science 0.1×
- Computer Science 0.1×
- Mathematics 0.1×
- Decision Sciences 0.1×
- Environmental Science 0.0×
Who are the top researchers at South Texas Accelerated Research Therapeutics?
Ranked on the composite score, Kyriakos P. Papadopoulos, Muralidhar Beeram and Amita Patnaik lead among researchers whose main affiliation is South Texas Accelerated Research Therapeutics.
- 1 Kyriakos P. Papadopoulos United States · #110,443 worldwide 380 citations · 89 works
- 2 Muralidhar Beeram United States · #208,896 worldwide 116 citations · 22 works
- 3 Amita Patnaik United States · #291,801 worldwide 323 citations · 106 works
- 4 Anthony W. Tolcher United States · #376,273 worldwide 313 citations · 100 works
- 5 Michael J. Wick United States · #404,971 worldwide 87 citations · 42 works
- 6 Drew Rasco United States · #499,931 worldwide 184 citations · 71 works
- 7 Nehal J. Lakhani United States · #822,915 worldwide 65 citations · 41 works
- 8 K. Papadopoulos United States · #1,374,022 worldwide 9 citations · 18 works
- 9 K. Papadopoulos United States · #1,423,479 worldwide 19 citations · 16 works
Which keywords describe research at South Texas Accelerated Research Therapeutics?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Breast Cancer, Immunotherapy, Tumor Microenvironment, Targeted Therapy, Metastatic Breast Cancer, Clinical Trials and Metastatic.
- Transcriptional Regulation
- Gene Therapy
- ALK Inhibitors
- Resistance Mechanisms
- Precision Medicine
- Genetic Mutations
- Prognostic Factors
- Molecular Subtypes
- Antibody Engineering
- Glycosylation
- Monoclonal Antibodies
- Cancer Therapy
- Palbociclib
- Immune Checkpoint Blockade
- Cell Cycle Control
- Cancer
- Metastatic
- Metastatic Breast Cancer
- Tumor Microenvironment
- Breast Cancer
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Clinical Trials
- CDK4/6 Inhibitors
- Cancer Immunotherapy
- HER2
- PD-1 and PD-L1
- Trastuzumab
- Tumor Regression
- Genomic Profiling
- Therapeutic Antibodies
- Fc Receptors
- Biomarkers
- PET Imaging
- Lymphoma
- Radiotherapy
- Treatment Guidelines
- EGFR Mutations
- Neoadjuvant Therapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy10▲ 20×14 topics
- Breast Cancer9▲ 56×6 topics
- Immunotherapy8▲ 16×14 topics
- Tumor Microenvironment6▲ 21×8 topics
- Targeted Therapy6▲ 39×5 topics
- Metastatic Breast Cancer5▲ 134×2 topics
- Clinical Trials5▲ 11×7 topics
- Metastatic4▲ 98×2 topics
- CDK4/6 Inhibitors4▲ 229×1 topic
- Cancer4▲ 4.2×20 topics
- Cancer Immunotherapy4▲ 37×3 topics
- Cell Cycle Control4▲ 191×2 topics
- HER24▲ 202×1 topic
- Immune Checkpoint Blockade4▲ 51×1 topic
- PD-1 and PD-L14▲ 51×1 topic
- Palbociclib4▲ 229×1 topic
- Trastuzumab4▲ 127×1 topic
- Cancer Therapy4▲ 9.3×14 topics
- Tumor Regression4▲ 48×2 topics
- Monoclonal Antibodies4▲ 58×3 topics
- Genomic Profiling4▲ 48×2 topics
- Glycosylation3▲ 44×2 topics
- Therapeutic Antibodies3▲ 69×2 topics
- Antibody Engineering3▲ 85×1 topic
- Fc Receptors3▲ 85×1 topic
- Molecular Subtypes3▲ 50×2 topics
- Biomarkers3▲ 5.9×4 topics
- Prognostic Factors3▲ 9.2×12 topics
- PET Imaging2▲ 21×4 topics
- Genetic Mutations2▲ 7.9×11 topics
- Lymphoma2▲ 19×2 topics
- Precision Medicine2▲ 6.6×4 topics
- Radiotherapy2▲ 8.1×6 topics
- Resistance Mechanisms2▲ 37×2 topics
- Treatment Guidelines2▲ 15×3 topics
- ALK Inhibitors2▲ 49×1 topic
- EGFR Mutations2▲ 49×1 topic
- Gene Therapy2▲ 16×4 topics
- Neoadjuvant Therapy2▲ 13×4 topics
- Transcriptional Regulation2▲ 18×7 topics
Which research topics does South Texas Accelerated Research Therapeutics publish most on?
By volume in 2022–2025: Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Cancer Immunotherapy and Biomarkers and Monoclonal and Polyclonal Antibodies Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 4 works
- 2 HER2/EGFR in Cancer Research Oncology 4 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 4 works
- 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 3 works
- 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 6 CAR-T cell therapy research Oncology 2 works
- 7 Colorectal Cancer Treatments and Studies Oncology 2 works
- 8 Cancer Research and Treatments Biotechnology 2 works
- 9 Cancer Genomics and Diagnostics Cancer Research 2 works
- 10 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has South Texas Accelerated Research Therapeutics's research output changed?
Output in 2018–2022 was 21% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in San Antonio
- The University of Texas at San Antonio Health Science Center
- The University of Texas at San Antonio
- Southwest Research Institute
- Trinity University
- San Antonio College
- Wilford Hall Ambulatory Surgical Center
- Brooke Army Medical Center
- Joint Base San Antonio
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.